Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miguel Torralba

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Diagnostics (Basel, Switzerland)|February 24, 2024
Prognostic Factors for Mortality in Hepatocellular Carcinoma at Diagnosis: Development of a Predictive Model Using Artificial IntelligencePablo Martínez-Blanco, Miguel Suárez, Sergio Gil-Rojas, et al.
Digestive Diseases and Sciences|May 30, 2026
Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning ApproachesPablo Martínez-Blanco, Miguel Suárez, Jorge Mateo, et al.
Metabolites|June 26, 2024
Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning TechniquesSergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, et al.
Iscience|December 29, 2023
IL-15 boosts activated HBV core-specific CD8<sup>+</sup> progenitor cells via metabolic rebalancing in persistent HBV infectionJulia Peña-Asensio, Henar Calvo-Sánchez, Joaquín Miquel, et al.
Cancers|March 28, 2024
Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient ManagementMiguel Suárez, Sergio Gil-Rojas, Pablo Martínez-Blanco, et al.
International Journal of Molecular Sciences|February 24, 2024
Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular CarcinomaSergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, et al.
European Journal of Hospital Pharmacy : Science and Practice|October 29, 2019
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient's satisfactionAna María Horta-Hernández, Begoña Esaclera-Izquierdo, Antonio Yusta-Izquierdo, et al.
Diabetes Technology & Therapeutics|July 1, 2024
Glycemic Risk Index in a Cohort of Patients with Type 1 Diabetes Mellitus Stratified by the Coefficient of Variation: A Real-Life StudySandra Herranz-Antolín, Clara Coton-Batres, María Covadonga López-Virgos, et al.
Acta Diabetologica|July 30, 2025
Time in Tight Range (TITR) stratified by Time Below Range (TBR) in a cohort of patients with type 1 Diabetes Mellitus and Multiple Daily Injections. A real-life studySandra Herranz-Antolín, Sofía Ramos-Garrido, Verónica Esteban-Monge, et al.
Endocrine|August 26, 2025
Time in Tight Range (TITR) stratified by Coefficient of Variation (CV) in a cohort of patients with type 1 Diabetes Mellitus and Multiple Daily Injections. A real-life studySandra Herranz-Antolín, Verónica Esteban-Monge, María Covadonga López-Virgos, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Diagnostics (Basel, Switzerland)|February 24, 2024
Prognostic Factors for Mortality in Hepatocellular Carcinoma at Diagnosis: Development of a Predictive Model Using Artificial IntelligencePablo Martínez-Blanco, Miguel Suárez, Sergio Gil-Rojas, et al.
Digestive Diseases and Sciences|May 30, 2026
Exploratory Comparison of Meld, Meld-Na, and Meld 3.0 Scores for Prognostic Assessment at Diagnosis in Hepatocellular Carcinoma Using Machine Learning ApproachesPablo Martínez-Blanco, Miguel Suárez, Jorge Mateo, et al.
Metabolites|June 26, 2024
Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning TechniquesSergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, et al.
Iscience|December 29, 2023
IL-15 boosts activated HBV core-specific CD8<sup>+</sup> progenitor cells via metabolic rebalancing in persistent HBV infectionJulia Peña-Asensio, Henar Calvo-Sánchez, Joaquín Miquel, et al.
Cancers|March 28, 2024
Machine Learning-Based Assessment of Survival and Risk Factors in Non-Alcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma for Optimized Patient ManagementMiguel Suárez, Sergio Gil-Rojas, Pablo Martínez-Blanco, et al.
International Journal of Molecular Sciences|February 24, 2024
Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular CarcinomaSergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, et al.
European Journal of Hospital Pharmacy : Science and Practice|October 29, 2019
High-dose oral methylprednisolone for the treatment of multiple sclerosis relapses: cost-minimisation analysis and patient's satisfactionAna María Horta-Hernández, Begoña Esaclera-Izquierdo, Antonio Yusta-Izquierdo, et al.
Diabetes Technology & Therapeutics|July 1, 2024
Glycemic Risk Index in a Cohort of Patients with Type 1 Diabetes Mellitus Stratified by the Coefficient of Variation: A Real-Life StudySandra Herranz-Antolín, Clara Coton-Batres, María Covadonga López-Virgos, et al.
Acta Diabetologica|July 30, 2025
Time in Tight Range (TITR) stratified by Time Below Range (TBR) in a cohort of patients with type 1 Diabetes Mellitus and Multiple Daily Injections. A real-life studySandra Herranz-Antolín, Sofía Ramos-Garrido, Verónica Esteban-Monge, et al.
Endocrine|August 26, 2025
Time in Tight Range (TITR) stratified by Coefficient of Variation (CV) in a cohort of patients with type 1 Diabetes Mellitus and Multiple Daily Injections. A real-life studySandra Herranz-Antolín, Verónica Esteban-Monge, María Covadonga López-Virgos, et al.
Pageof 8